Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1022 (LINC01022)

Target
LINC01022
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA) family, Other
01

Overview

Long intergenic non-protein coding RNA 1022 (LINC01022, TCONS_00013107) is a non-coding RNA transcript longer than 200 nucleotides, located in genomic regions that do not overlap annotated protein-coding genes. LINC01022 belongs to the lincRNA subfamily, which distinguishes it from other lncRNAs by its position away from coding loci. LincRNAs are typically involved in diverse regulatory processes, such as chromatin remodeling, modulation of gene expression, and RNA stabilization, often acting in a highly tissue-specific manner. Some lincRNAs influence neighboring gene activity through changes in chromatin structure or recruitment of transcription factors, but most are not directly linked to drug action or considered classic therapeutic targets. The biological role of LINC01022 specifically is not well characterized, but it fits the general profile of lincRNAs as regulatory RNA molecules important for fine control of genetic programs and genome architecture.

Other names
LINC01022TCONS_00013107
02

Biological functions

Regulation of transcriptionChromatin remodelingRNA stabilizationFine-tuning expression of nearby genesOther
03

Disease associations

Other (no direct, well-established role in common disease categories such as cancer, inflammation, neurological disease, cardiovascular disease, or infection for LINC01022 specifically; but lincRNAs as a class are frequently linked to gene regulatory roles in disease contexts)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1022 (LINC01022).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1022 (LINC01022).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call